AstraZeneca gets $486M to test if COVID-19 antibodies can provide 12 months of protection FDA panel agrees Alkermes' schizophrenia med works—but clashes on risks for those taking opioids You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0 Gilead posts full ulcerative colitis data for JAK med filgotinib Priothera raises €30M to trial ex-Novartis' S1P drug in AML Cambridge researchers use VR software to take a tour inside of their own cells Amid Regeneron's emergency use bid, former FDA chief says US 'too late' on mass manufacture of COVID-19 antibodies Featured Story | By Nick Paul Taylor AstraZeneca has secured $486 million from the U.S. government to fund two phase 3 clinical trials of its anti-SARS-CoV-2 antibody cocktail AZD7442. The larger of the two studies will assess the ability of the long-acting antibodies to prevent infection with the pandemic coronavirus for up to 12 months. read more |
| |
|---|
|
| | In our recent 90 Second Insight video, WCG ThreeWire's Molly Hair, Director of Site Engagement and Management, discusses how study staffing shortages due to COVID-19 are affecting clinical research in oncology. Visit wcgclinical.com to see how our Site Support and Augmentation Services can get your oncology trial back on track. |
Top Stories By Amirah Al Idrus Eli Lilly’s Zyprexa may be one of the best treatments out there for schizophrenia, but it’s not widely used because it can cause extreme weight gain. Alkermes thinks it has a solution and an FDA panel agreed—at least, kind of. read more By Amirah Al Idrus Messenger RNA (mRNA) candidates are among the front-runners in the race for a COVID-19 vaccine, with Moderna and tandem Pfizer and BioNTech planning to seek emergency approvals later this year. But vaccination is just the tip of the iceberg for mRNA technologies, which Yusuf Erkul, Ph.D., thinks could be more useful as treatments for cancer, COVID-19 and beyond. read more By Amirah Al Idrus Two months after Gilead’s JAK inhibitor hit an FDA roadblock in rheumatoid arthritis, the company unveiled full data for the drug, filgotinib, from an ulcerative colitis study involving more than 1,300 patients. Gilead detailed the rates of various side effects, including serious infections, herpes zoster, pulmonary embolism and opportunistic infections. read more By Nick Paul Taylor Priothera has raised €30 million ($35 million) to fund clinical trials of a S1P receptor modulate once in development at Novartis. The drug, mocravimod, will undergo testing in high-risk acute myeloid leukemia patients who are undergoing allogeneic hematopoietic stem cell transplantation. read more By Conor Hale Researchers at the University of Cambridge have developed software that takes super-resolution microscope scans and transforms them into a virtual, 3D worlds, allowing scientists to don a VR headset and take an interactive tour of individual cells and proteins. read more By Kyle Blankenship Days removed from its star turn in President Donald Trump's COVID-19 treatment, Regeneron's antibody cocktail could be on the fast track to an emergency approval. But if it gets there, will there be enough supply to meet this year's demand? That boat's already sailed, a former FDA chief warned. read more | | Experts in our field with 20+ yrs. experience in Viral Vector & Plasmid DNA (R&D, High Quality, GMP) manufacture for pre-clinical to commercial supply. Now part of the Cognate BioServices family, Cobra has rebranded – look around our updated website. Learn more. |
Resources Sponsored By: ICON Clinical Research Ltd The culture of clinical research is evolving from one directed by researchers to one driven by the needs of patients and those who care for them. Sponsored By: The PerkinElmer Signals Screening Team Creating integrated HCS workflows in a single platform increases accuracy; reduces time and helps to identify the most appropriate hits or drug candidates. Learn more about a reliable method for creating a more efficient, faster, 3D image and multi-parametric data analysis workflow. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Cascade Chemistry, API CDMO Struggling with complex chemistry to get APIs for clinical trials? Find out what to look for in an API CDMO partner to gain expertise and speed that lead to success. Sponsored by: EVERSANA An integrated compliance model can be the competitive differentiator to commercialization and move the needle from cost center to value. Learn How. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Formedix Learn how to save time and reduce costs and complexity by streamlining the clinical trial process. Sponsored by: LabVantage Want to leapfrog lengthy LIMS deployments and position your pharmaceutical lab for success? Find out how with LabVantage Solutions. Sponsored by: Thermo Fisher Scientific Learn how to safeguard supply, improve distribution and reduce program costs and risks Sponsored by: Clinical Ink Learn how the right data capture solution can prompt the patient to follow the correct procedures and automatically sort the responses, according to protocol. Sponsored by: Guidehouse While COVID-19 has shifted the rules of the healthcare industry, research shows there was already progress on changes being made for how pharma companies are launching products. Sponsored by: Blue Matter Consulting Senior executives from 16 biopharma companies share their thoughts on how COVID-19 will change how the industry engages with its customers. A complete Life Science Industry Snapshot in One Report Sponsored by: Evidation Health Achieving patient centricity depends on evolving how evidence is generated. Sponsored by: Outer Edge Technology Cybercriminals Are Actively Exploiting The Coronavirus Pandemic To Gain Entry To Enterprise Networks. Don’t Let Your Company Become The Next Ransomware Headline -- Make These Changes Now! Sponsored by: 4G Clinical This white paper addresses the complexity of basket and umbrella designs, and how modern technology is critical to run flexible, agile and quality-driven trials. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Sponsored by: Paysign Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all. Sponsored by: Cardinal Health 3PL Services Identifying opportunities to simplify channel strategies and business processes for biopharma companies, their customers and patients. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Medtech Innovation Week October 19-22 Drug Development Immersion: Live, Online Course October 21-22, 2020 | 9am - 3:30pm ET Become Fluent In Drug Development With Our Industry Expert October 21-22, 2020 | 9am - 3:30pm ET Learn How To Bring A Drug Successfully To Market Oct 21-22, 2020 | Live, Online BioBasics 101: The Biology of Biotech for the Non-Scientist: Live, Online Course November 12-13, 2020 | 9am - 3:30pm ET Drug Development Boot Camp® VIRTUAL 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now | Due to COVID19 provisions – training will be conducted VIRTUALLY | Same excellent total immersion training in new medicine development will be made available to experts who want to make a difference to patients. | 